BDKRB1 and Alzheimer disease: In normal aging and AD patients, the expression levels of LPR-1 decreased significantly in brain endothelial cells (Donahue et al., 2006), whereas B1R antagonist SSR240612 increased LRP-1 protein levels in cerebral microvessels (Lacoste et al., 2013).